RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/36889044http://www.w3.org/2000/01/rdf-schema#comment"Phenotype-gene analyses and the increasing availability of mega-databases have revealed the impaired human flavin-containing monooxygenase 3 (FMO3) variants associated with the metabolic disorder trimethylaminuria. In this study, a novel compound variant of FMO3, p.[(Val58Ile; Tyr229His)], was identified in a 1-year-old Japanese girl who had impaired FMO3 metabolic capacity (70%) in terms of urinary trimethylamine N-oxide excretion levels divided by total levels of trimethylamine and its N-oxide. One cousin in the family had the same p.[(Val58Ile); (Tyr229His)]; [(Glu158Lys; Glu308Gly)] FMO3 haplotype and had a similar FMO3 metabolic capacity (69%). In a family study, the novel p.[(Val58Ile); (Tyr229His)] compound FMO3 variant was also detected in the proband 1's mother and aunt. Another novel compound FMO3 variant p.[(Glu158Lys; Met260Lys; Glu308Gly; Ile426Thr)] was identified in a 7-year-old girl, proband 2. This novel compound FMO3 variant was inherited from her mother. Recombinant FMO3 Val58Ile; Tyr229His variant and Glu158Lys; Met260Lys; Glu308Gly; Ile426Thr variant showed moderately decreased capacities for trimethylamine N-oxygenation compared to wild-type FMO3. Analysis of trimethylaminuria phenotypes in family studies has revealed compound missense FMO3 variants that impair FMO3-mediated N-oxygenation in Japanese subjects; moreover, these variants could result in modified drug clearances."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.org/dc/terms/identifier"doi:10.1016/j.dmpk.2023.100490"xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Shimizu M."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Yamamoto A."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Yamazaki H."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Yokota Y."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Harano M."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Makiguchi M."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/author"Shimamura E."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/name"Drug Metab Pharmacokinet"xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/pages"100490"xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/title"A family study of compound variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects found by urinary phenotyping for trimethylaminuria."xsd:string
http://purl.uniprot.org/citations/36889044http://purl.uniprot.org/core/volume"50"xsd:string
http://purl.uniprot.org/citations/36889044http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/36889044
http://purl.uniprot.org/citations/36889044http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/36889044
http://purl.uniprot.org/uniprot/#_A0A024R8Z4-mappedCitation-36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/#_A0A0S2Z3R0-mappedCitation-36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/#_B7Z3M2-mappedCitation-36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/#_B7Z543-mappedCitation-36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/#_P31513-mappedCitation-36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/#_Q53FW5-mappedCitation-36889044http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/Q53FW5http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/36889044
http://purl.uniprot.org/uniprot/A0A0S2Z3R0http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/36889044